Physician profile
Aritra Sen
NPI 1760801955
$6,375.73
in general payments reported to CMS, 2019-2025
23 companies · $495 in 2025
The $495 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.89 · 2021: $11.93 · 2022: $158 · 2023: $4,585 · 2024: $1,041 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $1,723 · Travel and Lodging: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $1,722.89 |
| Travel and Lodging | $1,398.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,398.15 | 2023-2024 | Ion, Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $439.99 | 2022-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $341.38 | 2022-2025 | Airsupra, Tezspire, Breztri |
| Ceribell, INC. | $163.45 | 2023 | Ceribell Rapid Response Eeg |
| Genzyme Corporation | $136.51 | 2024 | |
| Baxter Healthcare | $131.37 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Abiomed | $121.61 | 2024 | Impella |
| Mylan Specialty L.P. | $103.68 | 2023-2024 | Yupelri |
| Insmed, INC. | $80.49 | 2023-2025 | Arikayce |
| Electromed, INC. | $77.82 | 2023-2025 | Smartvest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.81 | 2024 | Ofev |
| Novartis Pharmaceuticals Corporation | $42.83 | 2019 | |
| Inogen, INC. | $41.42 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Viatris Specialty LLC | $41.02 | 2025 | Yupelri |
| Grifols USA, LLC | $29.71 | 2025 | Prolastin-C Liquid |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $26.04 | 2025 | Ohtuvayre |
| Pfizer INC. | $25.19 | 2019 | |
| Merck Sharp & Dohme LLC | $23.14 | 2023 | |
| Ani Pharmaceuticals, INC. | $19.86 | 2024 | Purified Cortrophin Gel |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.87 | 2019 | |
| Amgen INC. | $16.37 | 2025 | Tezspire |
| Inspire Medical Systems, INC. | $16.09 | 2023 | Inspire |
| Pulmonx Corporation | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aritra Sen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.